NCI patient summary: 714-X is camphor-derived, promoted for immune cancer claims, not proven safe/effective, not FDA-approved, and subject to U.S. import ban.
714-X / Trimethylbicyclonitramine
Camphor-derived injectable or intralymphatic alternative cancer product developed by Gaston Naessens and promoted as immune support. 714-X is a camphor-derived compound associated with Gaston Naessens, somatid theory, and claims of restoring immune function against cancer. NCI PDQ notes no peer-reviewed study has shown it safe or effective for cancer, and FDA placed an import ban on 714-X.
NCI CAM index used to identify missing PDQ topics including 714-X, antineoplastons, Cancell, cartilage, Gonzalez regimen, hydrazine sulfate, and Newcastle disease virus.